Science Codex | End-Stage Heart Failure Patients Benefit from Injection of Millions of ... Science Daily (press release) 18, 2013 — A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ... Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With ... |
